An observational study to collect and analyze volatile markers in the exhaled breath of cancer (GI, Cervical, Colorectal, head, and neck) patients using the CanScan prototype developed by Kozhnosys. - NI

Kozhnosys Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Inclusion Criteria for GI, Cervical, Colorectal, head, and neck Cancer
•1. Willing to fill out the informed consent form
•2. Female in the age group 20 to 80 years Women with newly diagnosed cancer (GI, Cervical, Colorectal, head, and neck) with/without common medical conditions like Hypertension, Hyperlipidaemia, Hypothyroidism, Arthritis, Asthma, GERD, Diabetes, PCOD, Vitamin deficiencies, etc. -20 evaluable subjects (4 patients each with above-mentioned cancer)
•3. Confirmed cases of GI, Cervical, Colorectal, head, and neck cancer but not exposed to any previous treatment cycle/surgery.
•4. Cases confirmed through endoscopy, PAP smear, Colonoscopy, MRI/CT, Ultrasonography or blood tests.

•Exclusion Criteria for GI, Cervical, Colorectal, head, and neck cancer
•1. The age group is below 20 years.
•2. Any known illness within 2 weeks from breath collection.
•3. Already undergoing cancer treatment.
•4. Undergone surgery for cancer tumor removal.
•5. Undergoing chemo/radiation therapy for cancer treatment.
•6. Positive, but no GI, Cervical, Colorectal, head, and neck cancer on the later investigation (Positive Sonography but negative biopsy report).

发起方

Kozhnosys Private Limited